National Institute for Health and Care Excellence

National Institute for Health and Care Excellence We are an independent body providing evidence based guidance to improve health and social care.

Since 1999, NICE have provided the NHS, and those who rely on it for their care, with an increasing range of advice on effective, good value healthcare, and have gained a reputation for rigour, independence and objectivity. In April 2013 NICE gained new responsibilities for providing guidance for those working in social care.

"The fear of that second stroke does not dictate my life anymore." After his stroke, Peter lived with uncertainty. No on...
24/03/2026

"The fear of that second stroke does not dictate my life anymore."

After his stroke, Peter lived with uncertainty. No one knew what caused it.

A small implantable cardiac monitor detected atrial fibrillation – the hidden cause. It gave him the answers he needed. Peter got the right treatment and his life back.

👉Read Peter's story and discover how NICE healthtech guidance is helping life-changing innovations reach the patients who need them: https://indepth.nice.org.uk/PetersStory/index.html

UCLH - University College London Hospitals NHS Foundation Trust
British Cardiovascular Society, Cambridge University Hospitals NHS Foundation Trust

"My 3-year-old said, 'You're happy.' I did not realise I'd disappeared." For years, Ammaarah was just surviving with typ...
19/03/2026

"My 3-year-old said, 'You're happy.' I did not realise I'd disappeared."

For years, Ammaarah was just surviving with type 1 diabetes - always reacting, never in control.

Today, she’s thriving. A hybrid closed loop device monitors her glucose and adjusts insulin automatically. It’s given her the freedom to be fully present with her children and meant her first full night’s sleep in years.

Read Ammaarah's story and discover how NICE is supporting faster, fairer rollout of high-impact healthtech: https://indepth.nice.org.uk/AmmaarahsJourney/index.html

Diabetes UK, Breakthrough T1D, Greater Manchester Mental Health NHS Foundation Trust

13/03/2026

Health and care professionals, stay updated with NICE's latest guidelines via our WhatsApp updates channel.

📱On mobile? Join here: https://whatsapp.com/channel/0029Vacj8Bt8aKvIJ7kALm0Q

🖥️On desktop?

Scan the QR code in the video.

đź””Once subscribed hit the bell to stay notified.

New treatment option for menopausal hot flushes recommended for use on the NHS, with up to 500,000 potentially eligible....
11/03/2026

New treatment option for menopausal hot flushes recommended for use on the NHS, with up to 500,000 potentially eligible.

NICE has recommended fezolinetant (veoza) for moderate to severe hot flushes and night sweats for those whom HRT is not suitable.

đź”—https://www.nice.org.uk/news/articles/500-000-eligible-to-benefit-from-new-non-hormonal-treatment-for-hot-flushes-caused-by-menopause?utm_medium=organic&utm_source=facebook&utm_campaign=fezolinetant_menopause&utm_content=graphic

For Amelia and Peter, their son Rufus's first hours were critical. Born at high risk of infection, he needed antibiotics...
10/03/2026

For Amelia and Peter, their son Rufus's first hours were critical. Born at high risk of infection, he needed antibiotics urgently. But standard treatment carried a hidden danger: Rufus had a genetic variant that could cause permanent hearing loss from a common antibiotic.

A rapid genetic test changed everything. Within minutes, nurses identified the risk and switched to a safer alternative. Standard tests take days.

Today, Rufus is a healthy, thriving baby who passed his latest hearing test with flying colours.

Behind every statistic is a family like Rufus's.

✨With NICE's support, this rapid test is being piloted across 14 NHS neonatal units.

Read the full story of how this innovation is saving babies' hearing: https://www.nice.org.uk/news/blogs/saving-babies-hearing-how-a-world-first-rapid-genetic-test-is-transforming-neonatal-care?utm_medium=organic&utm_source=facebook&utm_campaign=healthtech_rufus&utm_content=graphic

Manchester University NHS Foundation Trust, RNID, National Institute for Health and Care Research, MFT Research and Innovation

03/03/2026

Ammaarah spent years with type 1 diabetes dictating her life. Then she got a hybrid closed loop device.

The technology monitors blood sugar and automatically adjusts insulin delivery. For Ammaarah, it meant her first full night's sleep in years and the freedom to be present with her children.

For developers of this revolutionary tech, our positive recommendation brought with it credibility, funding and a clear pathway to reach patients across the NHS. For people like Ammaarah, it changed lives.

If you’re developing a technology that can deliver real impact, NICE can help.

Explore support 👉https://bit.ly/3OCw13n https://www.nice.org.uk/what-nice-does/our-guidance/about-healthtech-guidance/nice-backing-the-healthtech-that-changes-lives/how-we-support-healthtech-commissioning?utm_medium=organic&utm_source=facebook&utm_campaign=healthtech_ammaarah&utm_content=video

Diabetes UK, Breakthrough T1D , Greater Manchester Mental Health NHS Foundation Trust

What if diabetes complications could be prevented before they start? https://www.nice.org.uk/news/articles/major-changes...
18/02/2026

What if diabetes complications could be prevented before they start?
https://www.nice.org.uk/news/articles/major-changes-to-type-2-diabetes-treatment-could-save-thousands-of-lives?utm_medium=organic&utm_source=facebook&utm_campaign=t2d_final&utm_content=graphic

New NICE guidance could prevent around 17,000 deaths over three years, and free up ÂŁ560 million for NHS reinvestment.

From today, people with type 2 diabetes should be offered SGLT2 inhibitors (known as 'flozins') alongside metformin from the start of treatment, rather than later in their care journey.

These medicines do more than manage blood sugar. They protect the heart and kidneys, particularly important given heart disease is the leading cause of death in people with type 2 diabetes.

12/02/2026

Twice-yearly infusion that offers hope of normal kidney function for nearly 12,000 people living with lupus nephritis has been recommended by NICE in final guidance.

Clinical trials showed 46% of patients achieved normal or near-normal kidney function, compared with 33% on existing treatment alone.

Find out more: https://www.nice.org.uk/guidance/indevelopment/gid-ta11478 ?utm_medium=organic&utm_source=facebook&utm_campaign=obinutuzumab&utm_content=finalvideo

06/02/2026

This time on NICE Talks: The asthma guideline one year on

One year ago, NICE, British Thoracic Society and The Scottish Intercollegiate Guidelines Network came together to publish a landmark guideline transforming how asthma is diagnosed and treated across the UK.

In this episode, we reflect on what's changed and what's next.

Featuring insights from Nazir Hussain, specialist pharmacist in respiratory care, at Dudley Integrated Health and Care NHS Trust, and other leading experts.

🎧 Listen now
https://www.nice.org.uk/news/podcasts/the-asthma-guideline-one-year-on?utm_medium=organic&utm_source=facebook&utm_campaign=asthma_nicetalks&utm_content=video

Address

2nd Floor, 2 Redman Place
London
E201JQ

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when National Institute for Health and Care Excellence posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category